rs117735243
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting
The NM_183065.4(TMEM107):c.*617C>T variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.00135 in 764,050 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 4 hom. )
Consequence
TMEM107
NM_183065.4 3_prime_UTR
NM_183065.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.07
Genes affected
TMEM107 (HGNC:28128): (transmembrane protein 107) This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BS2
High Homozygotes in GnomAdExome4 at 4 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM107 | ENST00000437139 | c.*617C>T | 3_prime_UTR_variant | Exon 5 of 5 | 1 | NM_183065.4 | ENSP00000402732.2 | |||
TMEM107 | ENST00000449985 | c.*666C>T | 3_prime_UTR_variant | Exon 2 of 2 | 1 | ENSP00000404753.2 | ||||
SNORD118 | ENST00000363593.1 | n.2C>T | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
TMEM107 | ENST00000532998.5 | c.*2103C>T | downstream_gene_variant | 2 | ENSP00000433148.1 |
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 197AN: 152064Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
197
AN:
152064
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00146 AC: 338AN: 231102Hom.: 2 AF XY: 0.00143 AC XY: 183AN XY: 127566
GnomAD3 exomes
AF:
AC:
338
AN:
231102
Hom.:
AF XY:
AC XY:
183
AN XY:
127566
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00137 AC: 837AN: 611866Hom.: 4 Cov.: 0 AF XY: 0.00136 AC XY: 454AN XY: 334362
GnomAD4 exome
AF:
AC:
837
AN:
611866
Hom.:
Cov.:
0
AF XY:
AC XY:
454
AN XY:
334362
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00129 AC: 197AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.00141 AC XY: 105AN XY: 74406
GnomAD4 genome
AF:
AC:
197
AN:
152184
Hom.:
Cov.:
32
AF XY:
AC XY:
105
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Leukoencephalopathy with calcifications and cysts Pathogenic:1Uncertain:1
Apr 06, 2020
Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Mar 12, 2018
Undiagnosed Diseases Network, NIH
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:2
Aug 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
SNORD118: BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at